Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses

[1]  Hyewon Shin,et al.  Molecular and cellular pharmacology Antipsychotics , chlorpromazine and haloperidol inhibit voltage-gated proton currents in BV 2 microglial cells , 2014 .

[2]  H. Tumani,et al.  Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases. , 2014, Cytokine.

[3]  R. Kahn,et al.  The neurobiology and treatment of first-episode schizophrenia , 2014, Molecular Psychiatry.

[4]  Steven C.R. Williams,et al.  Reduced Cortical Volume and Elevated Astrocyte Density in Rats Chronically Treated With Antipsychotic Drugs—Linking Magnetic Resonance Imaging Findings to Cellular Pathology , 2014, Biological Psychiatry.

[5]  Yu-Qiang Ding,et al.  Minocycline and Risperidone Prevent Microglia Activation and Rescue Behavioral Deficits Induced by Neonatal Intrahippocampal Injection of Lipopolysaccharide in Rats , 2014, PloS one.

[6]  Alessandra Bertoldo,et al.  Kinetic Modeling without Accounting for the Vascular Component Impairs the Quantification of [11C]PBR28 Brain PET Data , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  H. Moore,et al.  Dopamine D2 Receptors Regulate the Anatomical and Functional Balance of Basal Ganglia Circuitry , 2014, Neuron.

[8]  N. Andreasen,et al.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies , 2013, Neuroscience & Biobehavioral Reviews.

[9]  P. Buckley,et al.  Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects , 2013, Biological Psychiatry.

[10]  P. Buckley,et al.  Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  M. Cairns,et al.  Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia , 2013, Molecular Psychiatry.

[12]  F. Kirchhoff,et al.  Microglia: New Roles for the Synaptic Stripper , 2013, Neuron.

[13]  B. Bogerts,et al.  Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations? , 2012, Brain, Behavior, and Immunity.

[14]  S. Kapur,et al.  Contrasting Effects of Haloperidol and Lithium on Rodent Brain Structure: A Magnetic Resonance Imaging Study with Postmortem Confirmation , 2012, Biological Psychiatry.

[15]  Anatol C. Kreitzer,et al.  Plasticity in gray and white: neuroimaging changes in brain structure during learning , 2012, Nature Neuroscience.

[16]  F. Dickerson,et al.  Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia , 2012, Schizophrenia Research.

[17]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[18]  Takahiro A. Kato,et al.  Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? , 2011, Mini reviews in medicinal chemistry.

[19]  Shitij Kapur,et al.  Effect of Chronic Antipsychotic Treatment on Brain Structure: A Serial Magnetic Resonance Imaging Study with Ex Vivo and Postmortem Confirmation , 2011, Biological Psychiatry.

[20]  R. Kahn,et al.  Brain Volume Changes After Withdrawal of Atypical Antipsychotics in Patients With First-Episode Schizophrenia , 2011, Journal of clinical psychopharmacology.

[21]  Ronald Pierson,et al.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. , 2011, Archives of general psychiatry.

[22]  Yoshiro Okubo,et al.  Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. , 2010, The international journal of neuropsychopharmacology.

[23]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[24]  Rudi A. Dierckx,et al.  Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.

[25]  J. Nabekura,et al.  Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals , 2009, The Journal of Neuroscience.

[26]  Wagner F. Gattaz,et al.  Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[27]  T. Suslow,et al.  Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  R. Boellaard,et al.  Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study , 2008, Biological Psychiatry.

[29]  Allan R. Sampson,et al.  Effect of Chronic Antipsychotic Exposure on Astrocyte and Oligodendrocyte Numbers in Macaque Monkeys , 2008, Biological Psychiatry.

[30]  F. Dickerson,et al.  C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia , 2007, Schizophrenia Research.

[31]  B. Lopresti,et al.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging , 2006, Progress in Neurobiology.

[32]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[33]  B. Bogerts,et al.  Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization , 2006, Acta Neuropathologica.

[34]  P. R. Hof,et al.  Design-based stereology in neuroscience , 2005, Neuroscience.

[35]  Zhuoxin Sun,et al.  The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.

[36]  E. Lewandowska,et al.  Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. , 2005, Folia neuropathologica.

[37]  J. Lieberman,et al.  Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.

[38]  S. Kapur,et al.  Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[39]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[40]  J. Lieberman,et al.  Longitudinal study of brain morphology in first episode schizophrenia , 2001, Biological Psychiatry.

[41]  S. Arnold,et al.  Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia , 2000, Psychiatry Research.

[42]  L. Garey,et al.  Increase in HLA‐DR Immunoreactive Microglia in Frontal and Temporal Cortex of Chronic Schizophrenics , 2000, Journal of neuropathology and experimental neurology.

[43]  P. Falkai,et al.  Evidence for activation of microglia in patients with psychiatric illnesses , 1999, Neuroscience Letters.

[44]  J. Trojanowski,et al.  Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. , 1998, Archives of general psychiatry.

[45]  C. Montero-Menei,et al.  Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia , 1996, Brain Research.

[46]  Alan A. Wilson,et al.  Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. , 2015, Schizophrenia bulletin.

[47]  R. Kahn,et al.  Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. , 2014, Schizophrenia bulletin.

[48]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[49]  M. Toru,et al.  Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics , 2005, Journal of Neural Transmission.

[50]  R. Murray,et al.  Meta-analysis of regional brain volumes in schizophrenia. , 2000, The American journal of psychiatry.

[51]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .